Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma | MicrobiomeTrials← Back to trialsNCT06858501
Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-22Est. Completion: 2028-12-20
Enrollment target: 84 participants Other microbiome trials you might be interested in
Recurrent GanglioneuroblastomaRecurrent NeuroblastomaRefractory GanglioneuroblastomaRefractory Neuroblastoma
This phase I/II trial studies the side effects and best dose of iberdomide when given together with chemoimmunotherapy d…
Multiple LocationsEst. completion Sep 30, 2029
Ganglioneuroblastoma, NodularNeuroblastoma
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…
Birmingham, United States
Est. completion Dec 31, 2029
Congenital Central Hypoventilation Syndrome
The Center for Autonomic Medicine in Pediatrics (CAMP), in collaboration with leading CCHS clinicians, scientists, and p…
Chicago, United StatesEst. completion Dec 31, 2031